Conference Coverage

End-stage renal disease risk in lupus nephritis remains unchanged of late


 

FROM ARTHRITIS & RHEUMATOLOGY

References

The study was supported by the intramural research program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The authors reported having no conflicts of interest.

pwendling@frontlinemedcom.com

Pages

Recommended Reading

ACR: Don’t give pneumococcal vaccine to CAPS, Behçet’s patients
MDedge Family Medicine
ACR: Cryoglobulinemic vasculitis in Sjögren’s linked to lymphoma, mortality
MDedge Family Medicine
Steroid use down, biologic use rising in pregnancies of women with rheumatic disease
MDedge Family Medicine
Second dose of herpes zoster vaccine beneficial to seniors
MDedge Family Medicine
FDA approves selexipag for pulmonary arterial hypertension
MDedge Family Medicine
ACR: VEBs predict sudden cardiac death in systemic sclerosis
MDedge Family Medicine
ACR: First U.S. clinical practice guidelines arise for Sjögren’s syndrome management
MDedge Family Medicine
EADV: DLX105 is a novel treatment strategy for Behçet’s flares
MDedge Family Medicine
Biologic treatment in pregnancy requires balancing risks
MDedge Family Medicine
Axis I psychiatric disorders high in skin-restricted lupus patients
MDedge Family Medicine